Anne Chalumeau

532 total citations
11 papers, 187 citations indexed

About

Anne Chalumeau is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Anne Chalumeau has authored 11 papers receiving a total of 187 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 7 papers in Molecular Biology and 5 papers in Hematology. Recurrent topics in Anne Chalumeau's work include Hemoglobinopathies and Related Disorders (11 papers), CRISPR and Genetic Engineering (6 papers) and Iron Metabolism and Disorders (5 papers). Anne Chalumeau is often cited by papers focused on Hemoglobinopathies and Related Disorders (11 papers), CRISPR and Genetic Engineering (6 papers) and Iron Metabolism and Disorders (5 papers). Anne Chalumeau collaborates with scholars based in France, Italy and United Kingdom. Anne Chalumeau's co-authors include Annarita Miccio, Mario Amendola, Fulvio Mavilio, Jean‐Paul Concordet, Anna Cereseto, Giacomo Frati, Tristan Félix, Marina Cavazzana, Cécile Masson and Giuliana Ferrari and has published in prestigious journals such as Blood, Science Advances and Molecular Therapy.

In The Last Decade

Anne Chalumeau

9 papers receiving 186 citations

Peers

Anne Chalumeau
Kaitly J. Woodard United States
Suman Jain India
Marioara F. Ciuculescu United States
Sandra Fert‐Ferrer France
Beatriz Campo Fernandez United States
Shanhuo Yan China
Metrine Tendwa United Kingdom
Junbin Liang China
Nour J. Abdulhay United States
Zhaoling Xuan China
Kaitly J. Woodard United States
Anne Chalumeau
Citations per year, relative to Anne Chalumeau Anne Chalumeau (= 1×) peers Kaitly J. Woodard

Countries citing papers authored by Anne Chalumeau

Since Specialization
Citations

This map shows the geographic impact of Anne Chalumeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Chalumeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Chalumeau more than expected).

Fields of papers citing papers by Anne Chalumeau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Chalumeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Chalumeau. The network helps show where Anne Chalumeau may publish in the future.

Co-authorship network of co-authors of Anne Chalumeau

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Chalumeau. A scholar is included among the top collaborators of Anne Chalumeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Chalumeau. Anne Chalumeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Chalumeau, Anne, Guillaume Corre, Martin Peterka, et al.. (2025). A prime editing strategy to rewrite the γ-globin promoters and reactivate fetal hemoglobin for sickle cell disease. Blood. 146(22). 2641–2655. 1 indexed citations
2.
Frati, Giacomo, Mégane Brusson, Tristan Félix, et al.. (2024). Safety and efficacy studies of CRISPR-Cas9 treatment of sickle cell disease highlights disease-specific responses. Molecular Therapy. 32(12). 4337–4352. 8 indexed citations
3.
Rigonnot, Luc, Anne Chalumeau, Annarita Miccio, et al.. (2024). Cyclosporin H Improves the Transduction of CD34 + Cells with an Anti-Sickling Globin Vector, a Possible Therapeutic Approach for Sickle Cell Disease. Human Gene Therapy. 35(21-22). 896–903.
4.
Brusson, Mégane, Anne Chalumeau, Oriana Romano, et al.. (2023). Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies. Molecular Therapy — Nucleic Acids. 32. 229–246. 11 indexed citations
5.
Félix, Tristan, Anne Chalumeau, Giacomo Frati, et al.. (2022). Targeted Base Editing Strategies for Beta-Hemoglobinopathies. Blood. 140(Supplement 1). 7778–7779.
6.
Chalumeau, Anne, Tristan Félix, Antonio Casini, et al.. (2021). Combination of lentiviral and genome editing technologies for the treatment of sickle cell disease. Molecular Therapy. 30(1). 145–163. 7 indexed citations
7.
Pavani, Giulia, Anna Fabiano, Fatima Amor, et al.. (2021). Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells. Blood Advances. 5(5). 1137–1153. 60 indexed citations
8.
Chalumeau, Anne, Giacomo Frati, Elisa Magrin, & Annarita Miccio. (2021). Reverse Phase-high-performance Liquid Chromatography (RP-HPLC) Analysis of Globin Chains from Human Erythroid Cells. BIO-PROTOCOL. 11(2). e3899–e3899. 5 indexed citations
9.
Brusson, Mégane, Anne Chalumeau, Valentina Poletti, et al.. (2021). Novel Lentiviral Vectors for Gene Therapy of Sickle Cell Disease Combining Gene Addition and Gene Silencing Strategies. Blood. 138(Supplement 1). 3973–3973. 1 indexed citations
10.
Weber, Leslie, Giacomo Frati, Tristan Félix, et al.. (2020). Editing a γ-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype. Science Advances. 6(7). 93 indexed citations
11.
Frati, Giacomo, Leslie Weber, Tristan Félix, et al.. (2020). Editing the LRF Repressor Binding Site in the γ-Globin Promoters Induces Therapeutically Relevant Fetal Hemoglobin Levels for the Treatment of β-Hemoglobinopathies. Blood. 136(Supplement 1). 33–33. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaitly J. Woodard Breakdown of academic impact, for papers by Suman Jain Breakdown of academic impact, for papers by Marioara F. Ciuculescu Breakdown of academic impact, for papers by Sandra Fert‐Ferrer Breakdown of academic impact, for papers by Beatriz Campo Fernandez Breakdown of academic impact, for papers by Shanhuo Yan Breakdown of academic impact, for papers by Metrine Tendwa Breakdown of academic impact, for papers by Junbin Liang Breakdown of academic impact, for papers by Nour J. Abdulhay Breakdown of academic impact, for papers by Zhaoling Xuan
Rankless by CCL
2026